| Name | Title | Contact Details |
|---|
Bartels is a Issaquah, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Quick Med Claims (QMC) is a nationally recognized leader in emergency medical transportation billing and reimbursement. QMC is committed to providing services in a manner that ensures compliance with all applicable billing and reimbursement regulations, while maximizing the capture of allowable reimbursement for each client. The commitment to adherence to both of these principles makes QMC the partner of choice for emergency medical transportation providers. The company experience is deep enough and broad enough to ensure a high level of quality in all aspects of the service, while maintaining a manageable number of clients to provide individual attention for each. This balance has been the hallmark of the QMC approach since the foundation of the company. QMC is committed to the success of the emergency medical transportation programs that it supports and the existing client base has benefited from this commitment. QMC leadership works closely with client leadership to meet the strategic goals of the program and the sponsoring organizations.
BioSig Technologies, Inc. (OTCQB: BSGM) is a medical device company that is developing a proprietary technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig`s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and is working toward FDA 510(k) clearance for the PURE EP System.
The Association of State and Territorial Health Officials is a Arlington, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AccessElite, on a mission to inspire leaders to build healthier, happier organizations through optimal wellbeing.